Melatonin and andrographolide synergize to inhibit the colospheroid phenotype by targeting Wnt/beta‐catenin signaling
Daniil Sokolov(University of Maryland, Baltimore), Aditi Banerjee(University of Calcutta), Agnieszka Tarasiewicz(University of Maryland, Baltimore), Jaylyn Waddell(Ain Shams University), Neha Sharda(University of Maryland, Baltimore), Charity Lohr(University of Maryland, Baltimore), Banabihari Giri(University of Maryland, Baltimore), Tibor Kristián(University of Maryland, Baltimore), Damandeep Singh(University of Maryland, Baltimore), Rüssel J. Reiter(The University of Texas at San Antonio Health Science Center), Hafiz Ahmed(University of Maryland, Baltimore), Md Sazzad Hassan(Indiana University School of Medicine), Urs von Holzen(University of Basel)
Cited by 29
Related Papers
Melatonin as an antioxidant: under promises but over delivers
|Journal of Pineal Research|2016|1.7k
Melatonin Synthesis and Function: Evolutionary History in Animals and Plants
|Frontiers in Endocrinology|2019|685
The Safety of Melatonin in Humans
|Clinical Drug Investigation|2015|464
Melatonin: A Mitochondrial Targeting Molecule Involving Mitochondrial Protection and Dynamics
|International Journal of Molecular Sciences|2016|396